Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fully Remote Use of IpsiHand Device in Hemiparetic Stroke

NCT: NCT05965713 · COMPLETED

NCT IDNCT05965713
StatusCOMPLETED
Start Date2023-10-01
Completion2025-10-30
SponsorNeurolutions, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

BCI-REHAB was a randomized clinical trial comparing an at-home brain-computer interface therapy system versus an at-home exercise program for upper-extremity rehabilitation in the chronic phases of stroke. The purpose of the trial was to evaluate the efficacy of BCI-based therapy tested against standard exercise therapy and assess the potential for meaningful motor improvement in the home environment.

Frequently Asked Questions

What is Fully Remote Use of IpsiHand Device in Hemiparetic Stroke?

Fully Remote Use of IpsiHand Device in Hemiparetic Stroke is a clinical trial registered under NCT05965713. Current status: COMPLETED.

What is the status of NCT05965713?

The current status of NCT05965713 (Fully Remote Use of IpsiHand Device in Hemiparetic Stroke) is: COMPLETED.

When did Fully Remote Use of IpsiHand Device in Hemiparetic Stroke start?

Fully Remote Use of IpsiHand Device in Hemiparetic Stroke started on 2023-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.